ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,213.30
-0.22%
S&P ASX All Technology
3,719.30
-1.15%
Brent Oil
79.795
0.12%
US Dollar vs AUD
1.61168
-0.23%
Bitcoin
97,413.14
0.94%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. GH Research PLC (GHRS) Share Price

GH Research PLC

GH Research PLC (GHRS)

NASDAQ
8.19
0.00
(0.00%)
Closed 15 January 8:00AM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
8.19
Bid
5.49
Offer
9.06
Volume
-
0.00 Day's Range 0.00
5.50 52 Week Range 14.99
Market Cap
426.111M
Previous Close
8.19
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
74,743
Shares Outstanding
52,028,145
Dividend Yield
-
PE Ratio
-11.97
Earnings Per Share (EPS)
-0.68
Revenue
-
Net Profit
-35.59M

About GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ghres.com
Headquarters
Dublin, Irl
Founded
-
GH Research PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GHRS. The last closing price for GH Research was US$8.19. Over the last year, GH Research shares have traded in a share price range of US$ 5.50 to US$ 14.99.

GH Research currently has 52,028,145 shares in issue. The market capitalisation of GH Research is US$426.11 million. GH Research has a price to earnings ratio (PE ratio) of -11.97.

Ask ADVFN Intelligence (AI)

GHRS Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

10 January 2025
Edgar (US Regulatory)

GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents

Primary endpoint met in phase 2a POC trial in postpartum depression with a MADRS reduction from baseline of –35.4 points (p<0.0001, n=10) and 100% of patients in remission at Day 8Primary...

10 January 2025
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

05 December 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

15 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

14 November 2024
Edgar (US Regulatory)

GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 clinical trial to evaluate proprietary aerosol...

14 November 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

20 September 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 September 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

10 September 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

04 September 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.81-9998.021978078.49101895CS
4-0.01-0.1219512195128.210.236.72991058.05276508CS
12-0.1-1.206272617618.2911.096.72747438.43531429CS
26-3.71-31.176470588211.9146566238.62540346CS
522.2838.5786802035.9114.995.5747539.41344212CS
156-10.61-56.436170212818.821.325.057365910.53289436CS
260-13.81-62.77272727272230.435.058142113.28577593CS

GHRS - Frequently Asked Questions (FAQ)

What is the current GH Research share price?
The current share price of GH Research is US$ 8.19
How many GH Research shares are in issue?
GH Research has 52,028,145 shares in issue
What is the market cap of GH Research?
The market capitalisation of GH Research is USD 426.11M
What is the 1 year trading range for GH Research share price?
GH Research has traded in the range of US$ 5.50 to US$ 14.99 during the past year
What is the PE ratio of GH Research?
The price to earnings ratio of GH Research is -11.97
What is the reporting currency for GH Research?
GH Research reports financial results in GBP
What is the latest annual profit for GH Research?
The latest annual profit of GH Research is GBP -35.59M
What is the registered address of GH Research?
The registered address for GH Research is 28 BAGGOT STREET LOWER, DUBLIN 2, DUBLIN, D02 NX43
What is the GH Research website address?
The website address for GH Research is www.ghres.com
Which industry sector does GH Research operate in?
GH Research operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.995
(0.00%)
0
AACGATA Creativity Global
US$ 0.91995
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.995
(0.00%)
0
AACGATA Creativity Global
US$ 0.91995
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.995
(0.00%)
0
AACGATA Creativity Global
US$ 0.91995
(0.00%)
0

Discussion

View Full Feed
martyDg martyDg 4 minutes ago
Because LP is the perfect CEO of this company! She planned everything seamlessly. Per cult followers.
NWBO
GrantHorvat1 GrantHorvat1 5 minutes ago
Interesting that FUTS was touted as a clean shell...it is far from it. Veryyyyy interesting. Could work to our advantage however.

If anyone wants to know what a totally clean, debt free shell looks like check out G*VSI's latest annual...2024's will be filed imminently as well...the 8t
FUTS
Daytime_Lantern Daytime_Lantern 5 minutes ago
Hmm! Please elucidate regarding your statement ... "now I see something coming to shareholders that is really EXCITING!!" .

GLTA!
BIEL
Babubd Babubd 15 minutes ago
https://www.otcmarkets.com/otcapi/company/dns/news/document/79610/content
TRII
GrantHorvat1 GrantHorvat1 15 minutes ago
Looks like around 233k in debt to 3 noteholders issued around 5 years ago. Obviously more at this point with accrued interest owed. Still outstanding as far as I can tell.

So to the people who said this was a clean shell and debt free....wrong as usual 🙄.

But th
FUTS
mick mick 15 minutes ago
thank you
MasterBlastr MasterBlastr 22 minutes ago
Schauffele withdraws from The American Express for medical reasons

https://apnews.com/article/xander-schauffele-american-express-pga-tour-d2d984c7409ac312969147f9525d5f2a
aBeezlee aBeezlee 22 minutes ago
This is a highly speculative field. Rigetti may not match top companies in benchmarks, but that doesn't mean they can't cut out their own piece of the pie. I have no idea when they'll be profitable or show significant revenue, but we can't pretend to know the future.

I'm going to kee
RGTI
SkeBallLarry SkeBallLarry 25 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous ))) ... !!!
hyder hyder 25 minutes ago
Thanks and IMO you made a very wise investment decision. I am confident we will be wealthy soon. Go $$$$$NWBO$$$$$ 
NWBO
SkeBallLarry SkeBallLarry 25 minutes ago
" Thanks 'n Good Morning, CrudeOil " .. !!
mick mick 27 minutes ago
is scheffele wd
SkeBallLarry SkeBallLarry 27 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous ))) ... !!!
SkeBallLarry SkeBallLarry 29 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous, Bull ))) ... !!!
SkeBallLarry SkeBallLarry 30 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 31 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
eagle8 eagle8 31 minutes ago
Sorry to hear that XMaster.

All the best.
NWBO
Seminole Red Seminole Red 37 minutes ago
I wonder if it would be interesting to see the biggest Loosing stock of the day also ? sort of like a warning to whoever has it .
jeunke22 jeunke22 41 minutes ago
Lesson for all here. Reason I am long and positive like so many others here. Investing in Lightwave, a pre revenue company, is a question of belief, risk tolerance and the financial ability to persevere. It’s even more risky than investing in a revenue generating company like NVIDIA in 2018 as thi
LWLG
amelia43 amelia43 45 minutes ago
Shorting now is a very bad move.

To be fair, any hint of bad news will drop these down to the basement too.

Still shorting is not the move!
FNMA
GrantHorvat1 GrantHorvat1 45 minutes ago
Luis Rodriguez at 310-408-3826 is the latest we have.

If anyone has anything else let me know.
FUTS
pottsville pottsville 47 minutes ago
Yes we did several times
SMME
GrantHorvat1 GrantHorvat1 48 minutes ago
Does anyone here know if this shell still has anyone running things? At least keeping the lights on?

An attempt is going to try to be made to take things over here and buy the shell out between myself and my partner....perhaps 1 or 2 others. Get it current again and back trading. Lot
FUTS
Squirrely_McShitty Squirrely_McShitty 52 minutes ago
Do we know insiders & employees have received stock options? The last quarterly was issued in 2022 & last press release shortly thereafter. And frankly, stock options based on income that they have not shown to exist are not worth much.

But you could be correct in your hypothesis. No
CNNA
Cosa Cosa 58 minutes ago
If they creep up on those numbers in the next few years the market cap will move to $6 -$10 billion eventually.

Their guestimation:

Company reaffirms peak U.S. net IBSRELA sales revenue of greater than $1 Billion

Company announces peak U.S. net XPHOZAH
ARDX

Your Recent History

NASDAQ
GHRS
GH Research
EU
USC3N
Euronext US Screened Cli...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads